News

Currencies/Forex

GBPUSD Bearish Outlook Solid Despite Recent Rebound

GBPUSD Bearish Outlook Solid Despite Recent Rebound

Daffa Zaky | Equities.com |

The currency pair’s movement over the last two weeks was particularly driven by the recent political events in the U.K. coupled with mixed U.S. jobs data.


AUD/USD – Where to from Here?

BetaShares | Equities.com |

The Australian dollar has traded a wide up-trending range against the $US since early 2016, though appears to have broken below this range more recently.


The Dollar Will Continue Its Rally

Jared Dillian | Equities.com |

​Donald Trump is proposing really big tariffs, and the stock market doesn’t like it.


10 Banknotes From Around the World, and Their Security Features

Visual Capitalist | Equities.com |

The history of counterfeiting is almost as extensive as the history of money itself.


Pound Still Sensitive to Brexit Talks

RoboForex | Equities.com |

The Pound has been extremely “sensitive” to changes in investors’ sentiment, who were following the Brexit talks.


Traders Expect Continued Downward Pressure on GBPUSD Pair

Daffa Zaky | Equities.com |

any rebound is more likely to be a ‘dead cat bounce’ than a major change in direction of the exchange rate between GBP and USD.


​A Direct Play on the Strength of the Dollar

MoneyShow | Equities.com |

The dollar has been down so long, but the trend now looks like up


​Turmoil in Turkey Puts Pressure on World’s Stock Markets.

Michael Markowski | Equities.com |

The Lira's fall could accelerate the onset of a recession in Europe, which might then spread to the US.


​British Pound Rallies on Strong UK Retail Sales Data

Ben Myers | Equities.com |

The British Pound rallied on strong UK retail sales data which jumped by the highest amount in 18 months


The Role of Regulation in Online Forex Trading

Daffa Zaky | Equities.com |

Forex regulation is quite scarce at present despite of the huge size of the Forex market, and not a single global body exists to regulate it 24 hours a day.


Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Events

The MoneyShow San Francisco

Why should you join thousands of America's savviest investors and traders who make The MoneyShow San Francisco their can't-miss conference each summer? Because you will meet face-to-face and hear from…

Learn more